Biogen Inc. buy Royal Bank of Canada
Start price
09.11.23
/
50%
€211.40
Target price
09.11.24
€340.17
Performance (%)
-23.23%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.23%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 1.825% | 1.825% | -25.007% |
| iShares Core DAX® | -0.298% | 2.176% | 23.647% |
| iShares Nasdaq 100 | 3.125% | 6.718% | 18.974% |
| iShares Nikkei 225® | 1.935% | 11.107% | 23.404% |
| iShares S&P 500 | 1.920% | 4.314% | 10.905% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $351.00 to $363.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

